Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.27B |
| 2 |
Zimmer Biomet
ZBH
|
+$3.42B |
| 3 |
TransUnion
TRU
|
+$1.8B |
| 4 |
Qualcomm
QCOM
|
+$587M |
| 5 |
Alibaba
BABA
|
+$434M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$1.06B |
| 2 |
Pfizer
PFE
|
+$895M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$631M |
| 4 |
RTX Corp
RTX
|
+$546M |
| 5 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$516M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8.41% |
| 2 | Healthcare | 8.04% |
| 3 | Technology | 7.66% |
| 4 | Energy | 6.94% |
| 5 | Consumer Discretionary | 6.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
State Street SPDR S&P Homebuilders ETF
XHB
$1.68B
| $67.1M | 0.02% |
1,833,042
+4,302
| +0.2% | +$155K |
|
902
iShares US Healthcare ETF
IYH
$3.46B
| $67.1M | 0.02% |
2,113,185
+138,155
| +7% | +$4.35M |
|
903
Omega Healthcare
OHI
$15.4B
| $66.8M | 0.02% |
1,946,840
+274,260
| +16% | +$10.1M |
|
904
Applied Materials
AMAT
$382B
| $66.7M | 0.02% |
3,472,934
-1,067,304
| -24% | -$21.9M |
|
905
Revvity
RVTY
$12.4B
| $66.6M | 0.02% |
1,265,019
+270,526
| +27% | +$14.1M |
|
|
DRII
906
DELISTED
DIAMOND RESORTS INTL, INC
DRII
| $66.5M | 0.02% |
2,107,357
+114,923
| +6% | +$3.75M |
|
907
Williams-Sonoma
WSM
$27.7B
| $66.5M | 0.02% |
1,616,124
+50,874
| +3% | +$1.99M |
|
908
Genuine Parts
GPC
$17.8B
| $66.4M | 0.02% |
741,386
+123,319
| +20% | +$11.4M |
|
|
MON
909
PUT
DELISTED
Monsanto Co
MON
| $66.4M | 0.02% |
622,600
+107,300
| +21% | +$12.4M |
|
|
CELG
910
PUT
DELISTED
Celgene Corp
CELG
| $66.4M | 0.02% |
573,300
-59,500
| -9% | -$6.8M |
|
911
Coca-Cola Europacific Partners
CCEP
$49B
| $66.3M | 0.02% |
1,526,148
+176,452
| +13% | +$7.91M |
|
912
Stryker
SYK
$132B
| $66.3M | 0.02% |
693,524
-47,880
| -6% | -$4.54M |
|
913
PUT
Biogen
BIIB
$30.2B
| $66.2M | 0.02% |
164,000
-160,200
| -49% | -$64.3M |
|
914
CALL
Amgen
AMGN
$211B
| $66.2M | 0.02% |
431,000
+215,100
| +100% | +$34.5M |
|
915
Liberty Global Class A
LBTYA
$3.49B
| $66.1M | 0.02% |
1,483,232
-185,683
| -11% | -$8.25M |
|
|
B
916
DELISTED
Barnes Group Inc.
B
| $66M | 0.02% |
1,693,920
+632,115
| +60% | +$25.5M |
|
917
Republic Services
RSG
$67.1B
| $66M | 0.02% |
1,684,210
-54,864
| -3% | -$2.21M |
|
918
Cheniere Energy
LNG
$52.9B
| $65.8M | 0.02% |
949,372
+590,311
| +164% | +$44.2M |
|
|
LLL
919
DELISTED
L3 Technologies, Inc.
LLL
| $65.8M | 0.02% |
579,932
+84,238
| +17% | +$10M |
|
920
CALL
Nike
NKE
$63.6B
| $65.7M | 0.02% |
1,217,200
+502,200
| +70% | +$25.7M |
|
921
J.M. Smucker
SJM
$13.2B
| $65.7M | 0.02% |
605,845
-28,336
| -4% | -$3.28M |
|
922
Infosys
INFY
$49.9B
| $65.4M | 0.02% |
8,257,616
-209,652
| -2% | -$1.7M |
|
923
CALL
ConocoPhillips
COP
$139B
| $65.4M | 0.02% |
1,065,500
+288,200
| +37% | +$18.8M |
|
924
Waters Corp
WAT
$37.8B
| $65.3M | 0.02% |
508,684
+33,675
| +7% | +$4.37M |
|
|
DFT
925
DELISTED
DuPont Fabros Technology Inc.
DFT
| $65.2M | 0.02% |
2,215,605
-1,022,407
| -32% | -$32.5M |
|
Similar funds
Goldman Sachs's Q2 2015 Portfolio in Review
As of Q2 2015, Goldman Sachs held 7,731 positions worth $323B, up 3.7% from $311B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Goldman Sachs deployed $13.1B of net new capital in Q2 2015, opening 673 new positions and adding to 3,224 existing holdings. Its largest new stake was TransUnion: 72,355,340 shares worth $1.82B.
By sector, the portfolio is most concentrated in Financials at 8.4% of assets, up from 8% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Gilead Sciences, an estimated $1.06B trimmed.
- Goldman Sachs's largest Q2 2015 buy was TransUnion: 72,355,340 shares worth $1.82B.
- Goldman Sachs added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $4.27B increase.
- Goldman Sachs's biggest Q2 2015 reduction was Gilead Sciences, cutting an estimated $1.06B.
- Goldman Sachs fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $386M.
- Goldman Sachs's ten largest holdings make up 14% of its $323B portfolio in Q2 2015.
- Goldman Sachs opened 673 new positions and closed 497 in Q2 2015.
- Goldman Sachs's portfolio value rose 3.7% quarter-over-quarter to $323B.
Based on Goldman Sachs's 13F filing for Q2 2015, filed 14 Aug 2015.